Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen A Goldmuntz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Pediatrics|March 18, 2003
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndromeAlexei A Grom, Joyce Villanueva, Susan Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2020
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung FibrosisChiara Bellocchi, Jun Ying, Ellen A Goldmuntz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus ErythematosusCynthia Aranow, Diane L Kamen, Maria Dall'Era, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Pediatrics|March 18, 2003
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndromeAlexei A Grom, Joyce Villanueva, Susan Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2020
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung FibrosisChiara Bellocchi, Jun Ying, Ellen A Goldmuntz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus ErythematosusCynthia Aranow, Diane L Kamen, Maria Dall'Era, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.
Pageof 1